The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMed
The objective of this study is to determine the risk of tuberculosis (TB) disease in biologics users among rheumatoid arthritis (RA) patients in Taiwan from 2000 to 2015. This retrospective cohort study enrolled adult RA patients initiated on first biologics at Taichung Veterans General Hospital. TB …
The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted secur
Explore this link on the map →saved by
related reading
- Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody - PubMedpubmed.ncbi.nlm.nih.gov
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Breaking News: Historical Drop of DR-TB Treatment Cost Below $300 After Third Major Cut in 2025 by Stop TB’s Global Drug Facility | Stop TB Partnershipstoptb.org
- Lupus - Wikipediaen.wikipedia.org
- Preventing catastrophic pandemics | 80,000 Hours80000hours.org
- UpToDateuptodate.com
- Reasons to be pessimistic (and optimistic) on the future of biosecurityowlposting.com
- Why fixing the IRA matters to all of us - RApportrapport.bio
- UpToDateuptodate.com
- TNIK | Insilico Medicineinsilico.com
- UpToDateuptodate.com
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp